Ionic Homeostasis in Hypovolemia: Renal Mechanisms
Project Number5R01DK060726-02
Contact PI/Project LeaderSILVER, RANDI BETH
Awardee OrganizationWEILL MEDICAL COLL OF CORNELL UNIV
Description
Abstract Text
DESCRIPTION (provided by applicant): Keeping serum K+ within narrowly defined limits is critical for the maintenance of life. K+ homeostasis is an essential need of the body, but the means by which K^+ is conserved are poorly understood. K+-sparing is an important homeostatic component in response to volume depletion as may occur in such conditions as diarrhea, diuretic use, and congestive heart failure. The kidney adapts to volume depletion by reabsorbing more NaCI but the means by which K+ is conserved when NaCI is reabsorbed is not understood. The overall objective of this project is to elucidate the renal K+ conserving mechanisms involved in the adaptation to hypovolemia. I propose that K reabsorption occurs in volume depletion via a mechanism involving H+-K+-ATPase proteins present in the intercalated cells of the cortical collecting duct and these proteins are responsible for preserving K+-balance under conditions of volume depletion. Further, I propose that the apical Cl-/HCO-3 exchanger in the base secreting intercalated cell subtype, in cortical collecting duct, is the mechanism by which Cl-reabsorption accompanies Na+ reabsorption. Specific Aim I will examine the effect of volume depletion in in vitro studies on the activities of the H+-K+ ATPase and CI/HCO-3 exchanger in intercalated cells of cortical collecting tubules, and H+-K+-ATPase abundance and localization in renal cortex homogenate and in fixed kidney from control and volume depleted rats. In vivo studies will be performed on the effects of angiotensin, part of the renin-angiotensin-aldosterone system, which is stimulated in voluime depletion, on H+-K+-ATPase activity and Cl/HCO-3 exchange rate. Specific Aim II will investigate the role of angiotensin in acutely regulating the function of H+-K+-ATPases and the Cl-/HCO-3 exchanger in intercalated cells in vitro. Two signal transduction pathways associated with the actions of angiotensin will be studied in order to determine how angiotensin exerts its effects on intercalated cell transport. The overall premise for conducting these experiments is that if we understand the physiological basis by which the body normaIly conserves K+, then we will also have identified a target that potentially can be exploited for therapy of disorders of K+ metabolism.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
angiotensinsbicarbonateselectrolyte balancehydrogen potassium exchanging ATPasehypovolemialaboratory ratmembrane transport proteinspotassium ionrenal tubular transport
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
849
DUNS Number
060217502
UEI
YNT8TCJH8FQ8
Project Start Date
01-July-2002
Project End Date
30-April-2006
Budget Start Date
01-July-2003
Budget End Date
30-April-2004
Project Funding Information for 2003
Total Funding
$344,899
Direct Costs
$212,501
Indirect Costs
$132,398
Year
Funding IC
FY Total Cost by IC
2003
National Institute of Diabetes and Digestive and Kidney Diseases
$344,899
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01DK060726-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01DK060726-02
Patents
No Patents information available for 5R01DK060726-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01DK060726-02
Clinical Studies
No Clinical Studies information available for 5R01DK060726-02
News and More
Related News Releases
No news release information available for 5R01DK060726-02
History
No Historical information available for 5R01DK060726-02
Similar Projects
No Similar Projects information available for 5R01DK060726-02